These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 7043164

  • 1. Effect of a glucosidase inhibitor on the metabolic response of diabetic rats to a high carbohydrate diet, consisting of starch and sucrose, or glucose.
    Gray RS, Olefsky JM.
    Metabolism; 1982 Jan; 31(1):88-92. PubMed ID: 7043164
    [Abstract] [Full Text] [Related]

  • 2. Effects of an alpha-glucosidase inhibitor, acarbose, on blood glucose and serum lipids in streptozotocin-induced diabetic rats.
    Yamashita K, Sugawara S, Sakairi I.
    Horm Metab Res; 1984 Apr; 16(4):179-82. PubMed ID: 6373545
    [Abstract] [Full Text] [Related]

  • 3. [Effect of glucosidase inhibitor, Bay g 5421 (acarbose), on the blood glucose in obese diabetic patients ty pe 2 (NIDDM) (author's transl)].
    Laube H, Fouladfar M, Aubell R, Schmitz H.
    Arzneimittelforschung; 1980 Apr; 30(7):1154-7. PubMed ID: 7191299
    [Abstract] [Full Text] [Related]

  • 4. Effect of the alpha-glucosidase inhibitor Bay-O-1248 on the metabolic response of nondiabetic and diabetic rats to a high-carbohydrate diet.
    Madar Z, Olefsky J.
    Am J Clin Nutr; 1986 Aug; 44(2):206-11. PubMed ID: 3728357
    [Abstract] [Full Text] [Related]

  • 5. Acarbose reduces blood pressure in sucrose-induced hypertension in rats.
    Madar Z, Melamed EC, Zimlichman R.
    Isr J Med Sci; 1997 Mar; 33(3):153-9. PubMed ID: 9313782
    [Abstract] [Full Text] [Related]

  • 6. Effects of acarbose, an alpha-glucosidase inhibitor (Bay G 5421), on orally loaded glucose, maltose and sucrose and on blood glucose control in non-insulin-dependent diabetics.
    Hayakawa T, Noda A, Kondo T, Okumura N.
    Nagoya J Med Sci; 1985 Jan; 47(1-2):35-41. PubMed ID: 3887176
    [No Abstract] [Full Text] [Related]

  • 7. Metabolic consequences of the alpha-glucosidase inhibitor BAY-M-1099 given to nondiabetic and diabetic rats fed a high-carbohydrate diet.
    Madar Z.
    Am J Clin Nutr; 1989 Jan; 49(1):106-11. PubMed ID: 2643291
    [Abstract] [Full Text] [Related]

  • 8. [Modification of carbohydrate metabolism and oral glucose tolerance test in type II diabetics using the glucosidase inhibitor acarbose].
    Schwartzkopff W, Calder D.
    Med Welt; 1984 Feb 10; 35(6):169-74. PubMed ID: 6369065
    [No Abstract] [Full Text] [Related]

  • 9. Metabolic effects of acarbose in normal and diabetic rats: long- and short-term administration.
    Hess ME, Haugaard N, Min W, Torbati A.
    Arch Int Pharmacodyn Ther; 1986 Sep 10; 283(1):163-76. PubMed ID: 3800510
    [Abstract] [Full Text] [Related]

  • 10. alpha-Glucosidase inhibitors prevent diet-induced increases in intestinal sugar transport in diabetic mice.
    Casirola DM, Ferraris RP.
    Metabolism; 2006 Jun 10; 55(6):832-41. PubMed ID: 16713445
    [Abstract] [Full Text] [Related]

  • 11. Postprandial serum lipids and tissue lipoprotein lipase are acutely altered in rats by the alpha-glucosidase inhibitor acarbose.
    Picard F, Deshaies Y.
    Horm Metab Res; 1996 Aug 10; 28(8):377-80. PubMed ID: 8886823
    [Abstract] [Full Text] [Related]

  • 12. Effects of short-term low- and high-carbohydrate diets on postprandial metabolism in non-diabetic and diabetic subjects.
    Culling KS, Neil HA, Gilbert M, Frayn KN.
    Nutr Metab Cardiovasc Dis; 2009 Jun 10; 19(5):345-51. PubMed ID: 18083355
    [Abstract] [Full Text] [Related]

  • 13. The effect of acarbose and miglitol (BAY-M-1099) on postprandial glucose levels following ingestion of various sources of starch by nondiabetic and streptozotocin-induced diabetic rats.
    Madar Z.
    J Nutr; 1989 Dec 10; 119(12):2023-9. PubMed ID: 2695605
    [Abstract] [Full Text] [Related]

  • 14. Quercetin alleviates activities of intestinal and renal disaccharidases in streptozotocin-induced diabetic rats.
    Ramachandra R, Shetty AK, Salimath PV.
    Mol Nutr Food Res; 2005 Apr 10; 49(4):355-60. PubMed ID: 15744716
    [Abstract] [Full Text] [Related]

  • 15. Effect of acarbose (BAY-g-5421) on expression of noninsulin-dependent diabetes mellitus in sucrose-fed SHR/N-corpulent rats.
    Carswell N, Michaelis OE, Prather ES.
    J Nutr; 1989 Mar 10; 119(3):388-94. PubMed ID: 2646401
    [Abstract] [Full Text] [Related]

  • 16. Effect of sucrose and Acarbose feeding on the development of streptozotocin-induced diabetes in the rat.
    Goda T, Yamada K, Sugiyama M, Moriuchi S, Hosoya N.
    J Nutr Sci Vitaminol (Tokyo); 1982 Feb 10; 28(1):41-56. PubMed ID: 6212654
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The mechanism of alpha-glucosidase inhibition in the management of diabetes.
    Bischoff H.
    Clin Invest Med; 1995 Aug 10; 18(4):303-11. PubMed ID: 8549017
    [Abstract] [Full Text] [Related]

  • 19. [Clinical experience with an alpha glucosidase inhibitor (acarbose) in the treatment of non-insulin-dependent diabetes. Multicenter study].
    García de los Ríos M, Mujica V, Muñoz S, Durruty P, Larenas G, López MI, Kuzmanic A, Pérez J, Flaskamp R, Cumsille F.
    Rev Med Chil; 1997 Aug 10; 125(8):856-62. PubMed ID: 9580485
    [Abstract] [Full Text] [Related]

  • 20. Metabolic effects of acarbose administration in normal and diabetic rats.
    Haugaard N, Hess ME, Locke CL, Torbati A, Wildey G.
    Biochem Pharmacol; 1984 May 01; 33(9):1503-8. PubMed ID: 6732866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.